Effect of postoperative chemotherapy on the serum alpha-fetoprotein level in hepatoblastoma.

[1]  Y. Hata.  The clinical features and prognosis of hepatoblastoma: Follow-up studies done on pediatric tumors enrolled in the Japanese pediatric tumor registry between 1971 and 1980. Part I , 1990, The Japanese journal of surgery.

[2]  G. Leverger,et al.  Carboplatin‐epirubicin regimen for the treatment of hepatoblastoma , 2004, Pediatric blood & cancer.

[3]  D. V. von Schweinitz,et al.  Pretreatment prognostic factors and treatment results in children with hepatoblastoma , 2002, Cancer.

[4]  N. Ohnuma,et al.  Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: A report from the Japanese Study Group for Pediatric Liver Tumor. , 2002, Journal of pediatric surgery.

[5]  Y. Tsuchida,et al.  A case of well-differentiated, fetal-type hepatoblastoma with very low serum alpha-fetoprotein. , 1999, Journal of pediatric surgery.

[6]  K. Leibundgut,et al.  The role of subfractionation of alpha-fetoprotein in the treatment of pediatric surgical patients. , 1997, Journal of pediatric surgery.

[7]  T. Honna,et al.  The ratio of fucosylation of alpha‐fetoprotein in hepatoblastoma , 1989, Cancer.

[8]  M. Kaneko,et al.  Three different types of alpha-fetoprotein in the diagnosis of malignant solid tumors: use of a sensitive lectin-affinity immunoelectrophoresis. , 1989, Journal of pediatric surgery.

[9]  G. Abelev.  Alpha-fetoprotein: 25 years of study. , 1989 .

[10]  M. Isemura,et al.  The fucosylation index of alpha‐fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma , 1988, Cancer.

[11]  T. Yamane,et al.  Hormonal Control of α-Fetoprotein Secretion in Human Hepatoma Cell Lines Proliferating in Chemically Defined Medium , 1985 .

[12]  F. Becker,et al.  Alpha-Fetoprotein 3 , 1978 .